Association of circulating levels of asymmetric dimethylarginine (ADMA) with carotid intima-media thickness: Evidence from 6168 participants

Ageing Research Reviews

Volumn 12, Issue 2, 2013, Pages 699-707

  Bai, Yongyi ^a,b   Sun, Lan ^a   Du, Lida ^a,c   Zhang, Tiantai ^a   Xin, Wenyu ^a   Lan, Xi ^a   Du, Guanhua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine (ADMA); Carotid intima media thickness (IMT); Meta analysis

Indexed keywords

N(G),N(G) DIMETHYLARGININE;

ARTERIAL WALL THICKNESS; CHRONIC KIDNEY DISEASE; COMMON CAROTID ARTERY; GENETIC HETEROGENEITY; HUMAN; INTERNAL CAROTID ARTERY; KIDNEY FUNCTION; META ANALYSIS; PLASMA; REVIEW; SYSTEMATIC REVIEW;

ADULT; AGED; ARGININE; CAROTID INTIMA-MEDIA THICKNESS; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; RENAL INSUFFICIENCY, CHRONIC; STATISTICS AS TOPIC;

EID: 84878560476     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2012.02.003     Document Type: Review

References (40)

1. Atzeni F., Sarzi-Puttini P., Sitia S., et al. Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritis. J. Rheumatol. 2011, 38:1661-1664.
2. Ayer J.G., Harmer J.A., Nakhla S., et al. HDL-cholesterol, blood pressure, and asymmetric dimethylarginine are significantly associated with arterial wall thickness in children. Arterioscler. Thromb. Vasc. Biol. 2009, 29:943-949.
3. Brundtland G.H. From the World Health Organization. Reducing risks to health, promoting healthy life. J. Am. Med. Assoc. 2002, 288:1974.
4. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 2000, 87:840-844.
5. Chirinos J.A., David R., Bralley J.A., et al. Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study. Hypertension 2008, 52:1051-1059.
6. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
7. Egger M., Davey Smith G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 1997, 315:629-634.
8. Furuki K., Adachi H., Matsuoka H., et al. Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: an epidemiological study. Atherosclerosis 2007, 191:206-210.
9. Fuster V., Kelly B.B., Vedanthan R. Global cardiovascular health: urgent need for an intersectoral approach. J. Am. Coll. Cardiol. 2011, 58:1208-1210.
10. Heutling D., Schulz H., Nickel I., et al. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment. J. Clin. Endocrinol. Metab. 2008, 93:82-90.
11. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. Br. Med. J. 2003, 327:557-560.
12. Kanazawa I., Yano S., Notsu Y., et al. Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus. Clin. Endocrinol. (Oxf) 2011, 74:467-472.
13. Kawashima S., Yamashita T., Ozaki M., et al. Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 2001, 21:201-207.
14. Kocak H., Gumuslu S., Ermis C., et al. Oxidative stress and asymmetric dimethylarginine is independently associated with carotid intima media thickness in peritoneal dialysis patients. Am. J. Nephrol. 2008, 28:91-96.
15. Kumagai H., Sakurai M., Takita T., et al. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients. Am. J. Kidney Dis. 2006, 48:797-805.
16. Leong T., Zylberstein D., Graham I., et al. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg. Arterioscler. Thromb. Vasc. Biol. 2008, 28:961-967.
17. Lipinski M.J., Biondi-Zoccai G.G., Abbate A., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J. Am. Coll. Cardiol. 2007, 50:1761-1767.
18. Maas R., Schulze F., Baumert J., et al. Asymmetric dimethylarginine smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data. Clin. Chem. 2007, 53:693-701.
19. Maas R., Xanthakis V., Polak J.F., et al. Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort. Stroke 2009, 40:2715-2719.
20. Meinitzer A., Seelhorst U., Wellnitz B., et al. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin. Chem. 2007, 53:273-283.
21. Miyazaki H., Matsuoka H., Cooke J.P., et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999, 99:1141-1146.
22. Nanayakkara P.W., Teerlink T., Stehouwer C.D., et al. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure. Kidney Int. 2005, 68:2230-2236.
23. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 1999, 340:14-22.
24. Pamuk B.O., Torun A.N., Kulaksizoglu M., et al. Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters. Fertil. Steril. 2010, 93:1227-1233.
25. Perez-Vizcaino F., Duarte J., Andriantsitohaina R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic. Res. 2006, 40:1054-1065.
26. Petrica L., Petrica M., Vlad A., et al. Proximal tubule dysfunction is dissociated from endothelial dysfunction in normoalbuminuric patients with type 2 diabetes mellitus: a cross-sectional study. Nephron. Clin. Pract. 2011, 118:c155-c164.
27. Saadany H.E., El-Sergany M., Kasem E., et al. Biochemical and genetic risk factors for atherosclerosis in systemic lupus erythematosus. Egypt. Rheumatol. 2011, 33:35-43.
28. Schnabel R., Blankenberg S., Lubos E., et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ. Res. 2005, 97:e53-e59.
29. Sen N., Poyraz F., Tavil Y., et al. Carotid intima-media thickness in patients with cardiac syndrome X and its association with high circulating levels of asymmetric dimethylarginine. Atherosclerosis 2009, 204:e82-e85.
30. Serg M., Kampus P., Kals J., et al. Association between asymmetric dimethylarginine and indices of vascular function in patients with essential hypertension. Blood Press. 2011, 20:111-116.
31. Surdacki A., Martens-Lobenhoffer J., Wloch A., et al. Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 2007, 56:809-819.
32. Suwaidi J.A., Hamasaki S., Higano S.T., et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000, 101:948-954.
33. Turiel M., Atzeni F., Tomasoni L., et al. Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. Rheumatology (Oxford) 2009, 48:834-839.
34. Vladimirova-Kitova L., Terzieva D., Marinov B. Intima-media thickness and flow-mediated vasodilation in asymptomatic subjects with newly detected severe hypercholesterolemia. Echocardiography 2009, 26:1060-1068.
35. Wanby P., Teerlink T., Brudin L., et al. Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population. Atherosclerosis 2006, 185:271-277.
36. Welten D.C., Kemper H.C., Post G.B., et al. A meta-analysis of the effect of calcium intake on bone mass in young and middle aged females and males. J. Nutr. 1995, 125:2802-2813.
37. Zhang W.R., Hou F.F., Ning J.P., et al. Level of asymmetric dimethylarginine and carotid atherosclerosis in patients with chronic kidney disease. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006, 31:621-628.
38. Zoccali C., Benedetto F.A., Maas R., et al. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J. Am. Soc. Nephrol. 2002, 13:490-496.
39. Zoccali C., Bode-Boger S., Mallamaci F., et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001, 358:2113-2117.
40. Zsuga J., Torok J., Magyar M.T., et al. Serum asymmetric dimethylarginine negatively correlates with intima-media thickness in early-onset atherosclerosis. Cerebrovasc. Dis. 2007, 23:388-394.